We were founded to bring clarity, evidence, and real medical progress to hair loss care.
Pattern hair loss is a medical condition that has been systemically failed by weak evidence, unvalidated claims, and patient confusion. It’s time to change that.
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company developing innovative therapeutics for pattern hair loss. We are currently developing VDPHL01:
- Designed to be the first non-hormonal oral hair loss treatment for men and women.
- Evaluated through the rigorous, large-scale, placebo-controlled clinical trials required to prove real, consistent results.
Our mission
To set a new standard in pattern hair loss by developing treatments rooted in real evidence.
FEATURED NEWS
February 9, 2026
Pattern hair loss deserves real science.
A profound unmet need
Pattern hair loss transcends mere aesthetics. It’s deeply personal, psychological, and essentially universal, yet the standard of care has not meaningfully changed in decades.
Deep roots
Our seasoned management team has long-term experience in dermatology and the pattern hair loss community.
Commitment to growth
Three Phase 3 clinical trials underway in pattern hair loss, marking the first Phase 3 trials for an oral therapy in nearly 30 years and the first ever in the US for female pattern hair loss.